Algerian authorities have vowed they will not give up on the controversial use of hydroxychloroquine in the treatment against coronavirus, despite the decision of the World Health Organization (WHO) to suspend clinical trials, a member of the Pandemic Monitoring Committee said Tuesday.
“We have treated thousands of cases with this drug with great success to date. And we have not noted any adverse reactions,” Dr. Mohamed Bekkat, a member of the Scientific Committee monitoring the evolution of the Covid-19 pandemic in Algeria, told AFP.
“We have not recorded any deaths related to the use of (hydroxy)chloroquine,” said Dr. Bekkat, also president of the Council of the Algerian Medical Association.
Data Source: Africa News
